Medicare Drug Plans Are Hiking Premiums While Trump Claims Victory on Medicine Prices

Average monthly premiums for stand-alone Medicare Part D prescription drug plans are projected to surge by 50% in 2027, according to a new analysis. The anticipated price increase will impact millions of beneficiaries, contrasting sharply with political rhetoric touting lower prescription costs. Analysts note that enrollees can potentially mitigate these higher costs by actively shopping and switching to lower-cost plans during open enrollment.